"/> Novus Biologicals™ Peptide bloquant d’anticorps BI… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps BIRC8

Réf. : BL-RE-048345Réf. fabricant : 18298945 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
112401
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76669. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 12 amino amino terminus of human ILP-2.

Points forts

Source

Synthetic

(Accession #: NP_203127) The BIRC8 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-048345
Réf. fabricant18298945
Gene ID (Entrez)112401
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76669. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gènebaculoviral IAP repeat containing 8, baculoviral IAP repeat-containing 8, baculoviral IAP repeat-containing protein 8, hILP2, IAP-like protein 2, ILP-2 ILP2, Inhibitor of apoptosis-like protein 2, Testis-specific inhibitor of apoptosis
Symbole de gène(s)BIRC8
Type de produitBIRC8
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne12 amino amino terminus of human ILP-2
Une question, une configuration particulière ?
Contactez-nous pour un devis.